Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.05 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | hard to drug | 0.00 |
| trials ClinicalTrials.gov | 1 Parkinson's trial, 1 stopped | 0.20 |
| literature PubMed | 14 Parkinson's papers of 2,296 | 0.64 |
| pathways Reactome | 5 pathways; mostly protein handling | 0.90 |
No case: the score is under the bar. Receipt 5074
Sealed predictions
- PER1 in dopamine neurons, braak-0.52 (p 0.154) → -0.72 (p 0.029)receipt 5081
Swarm cases
receipt 5081: PER1 in dopamine neurons, braak
- power
- full sample -0.63 (p 0.0051, n 18), 95% CI -0.85 to -0.23. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.63 (p 0.0051, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.60 (p 0.0080, n 18). not the mix.
- skeptic
- leave-one-out range -0.76 to -0.58, sign flips 0; without severely affected donors -0.63 (p 0.0051, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for PER1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts